Bangladesh Pharmaceuticals & Healthcare Q4 2018
Despite low public expenditure on healthcare, Bangladesh’s pharmaceutical market will continue to post high growthrates over the forecast period. Low affordability levels will ensure low-cost generic drugs continue to outperform. Although existingincentives to localise drug production, together with the market’s long-term development potential, will continue to drive industrialdevelopment, multinational investment appetite in the sector will remain low due to high country risks and a weak businessenvironment.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook